Estrella ImmunopharmaESLA
13F holders, Q2 2025 (June 30)11holders
1new positions
1sold out
1famous investor
$0.88avg. 13F price*
At the end of Q2 2025, 11 institutions reported holding Estrella Immunopharma Inc. (ESLA) in their 13F filings, unchanged from Q1 2025. 1 opened new positions and 1 sold out. The largest holders were Vanguard Group Inc. ($242K), Geode Capital Management, LLC ($89K) and UBS Group AG ($70K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Estrella Immunopharma Inc.
- CUSIP
- 297584104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $14K |
| Exits | 1 | $21 |
All 13F filers, Q1 2025 → Q2 2025: 64,193 shares bought and 42,519 shares sold, net +21,674 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| Vanguard Group Inc. | 0.00% | Add +1.9% | 282,843 | $242K |
| Geode Capital Management, LLC | 0.00% | Add +3.2% | 103,337 | $89K |
| UBS Group AG | 0.00% | Add +77.3% | 72,773 | $70K |
| Citadel Advisors | 0.00% | Reduce -45.2% | 50,156 | $43K |
| Atw Spac Management LLC | 0.06% | No change | 40,000 | $38K |
| BlackRock, Inc. | 0.00% | Add +27.4% | 31,407 | $30K |
| State Street Corp. | 0.00% | No change | 22,352 | $19K |
| HRT Financial LP | 0.00% | New | 17,266 | $14K |
| MASO CAPITAL PARTNERS Ltd | 0.02% | No change | 10,000 | $10K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -18.6% | 4,593 | $4K |
| Bank of America Corp. | 0.00% | Add +5.8% | 92 | $89 |
"% of holder's portfolio" is ESLA's weight in each manager's 13F, not the share of Estrella Immunopharma Inc. the manager owns.